3AB-28322-53910
3 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 549 / WI
- Registered
- 2021-10-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2021-01-19
Dose 2 — Pfizer-BioNTech
-
2021-10-05
Dose 3 — Pfizer-BioNTech
-
2021-10-06
Registered in v-safe
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to work or attend schoolAdult check-in
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-04
- 2021-11-09
- 2021-11-16
-
2022-01-06
Survey response — 3 months, dose 3MedDRA: Influenza — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Influenza AMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | No |
| 2 | 2021-01-19 | Pfizer-BioNTech | No |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 3
Symptoms: Influenza A
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release